| PDF - Published Version (2MB) |
- URN to cite this document:
- urn:nbn:de:bvb:355-epub-444953
- DOI to cite this document:
- 10.5283/epub.44495
This publication is part of the DEAL contract with Springer.
Abstract
BackgroundLeukaemia is the most prevalent form of cancer-causing death in a large number of populations and needs prompt and effective treatment. Chemotherapeutics can be used to treat leukaemia, but their pronounced killing effects to other living cells is still an issue. Active targeting to certain specific receptors in leukaemic cells is the best way to avoid damage to other living cells. ...

Owner only: item control page